261 results on '"Gareen, Ilana F."'
Search Results
2. Utilization of Diagnostic Procedures After Lung Cancer Screening in the National Lung Screening Trial
3. Study protocol for a hybrid type 1 effectiveness-implementation trial testing virtual tobacco treatment in oncology practices [Smokefree Support Study 2.0]
4. Testing the effectiveness of a virtual sustained tobacco treatment: Initial reporting of findings from the EAQ171CD randomized clinical trial conducted by ECOG-ACRIN within the NCI Community Oncology Research Program (NCORP).
5. Patient-Reported Adverse Events and Early Treatment Discontinuation Among Patients With Multiple Myeloma
6. Racial Differences in Smoking-related Disease Risk Perceptions Among Adults Completing Lung Cancer Screening : Follow-up Results from the ACRIN/NLST Ancillary Study
7. Medical Care Costs Were Similar Across the Low-dose Computed Tomography and Chest X-Ray Arms of the National Lung Screening Trial Despite Different Rates of Significant Incidental Findings
8. Supplemental Table 1 from Cigarette and Alternative Tobacco Product Use among Adult Cancer Survivors Enrolled in 9 ECOG-ACRIN Clinical Trials
9. Supplemental Table 2 from Cigarette and Alternative Tobacco Product Use among Adult Cancer Survivors Enrolled in 9 ECOG-ACRIN Clinical Trials
10. Data from Cigarette and Alternative Tobacco Product Use among Adult Cancer Survivors Enrolled in 9 ECOG-ACRIN Clinical Trials
11. Amyloid Positron Emission Tomography and Subsequent Health Care Use Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia
12. The effect of neighborhood socioeconomic disadvantage on smoking status, quit attempts, and receipt of cessation support among adults with cancer: Results from nine ECOG‐ACRIN Cancer Research Group trials
13. Separating Actionable From Incidental Findings—Imperative for Meaningful Clinical Outcomes—Reply
14. Failure of Macrolide Antibiotic Treatment in Patients with Bacteremia Due to Erythromycin-Resistant Streptococcus pneumoniae
15. Intrauterine Devices and Pelvic Inflammatory Disease: Meta-Analyses of Published Studies, 1974-1990
16. Cigarette and Alternative Tobacco Product Use among Adult Cancer Survivors Enrolled in 9 ECOG-ACRIN Clinical Trials
17. Significant Incidental Findings in the National Lung Screening Trial
18. The effect of neighborhood socioeconomic disadvantage on smoking status, quit attempts, and receipt of cessation support among adults with cancer: Results from nine ECOG‐ACRIN Cancer Research Group trials.
19. Importance of Low- and Moderate-Grade Adverse Events in Patients' Treatment Experience and Treatment Discontinuation: An Analysis of the E1912 Trial.
20. HYPERTENSION, CARDIOVASCULAR EVENTS AND SURVIVAL IN RENAL CELL CARCINOMA AND THYROID CANCER PATIENTS TREATED WITH VEGFR TYROSINE KINASE INHIBITORS
21. The Relations Between False Positive and Negative Screens and Smoking Cessation and Relapse in the National Lung Screening Trial : Implications for Public Health
22. A Testament to Sustained Macrolide Efficacy [with Reply]
23. Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or Dementia
24. Identifying and collecting pertinent medical records for centralized abstraction in a multi-center randomized clinical trial: The model used by the American College of Radiology arm of the National Lung Screening Trial
25. A Qualitative Study of Lung Cancer Risk Perceptions and Smoking Beliefs Among National Lung Screening Trial Participants
26. Adjusting the TMIST study design to accommodate slower than expected accrual: ECOG-ACRIN EA1151.
27. Predictive value of baseline patient-rated treatment bother for early anastrozole discontinuation in a racially diverse cohort: Results from ECOG-ACRIN E1Z11.
28. Neighborhood socioeconomic disadvantage, tobacco use, and cessation indicators among adults with cancer in the United States: Results from 10 ECOG-ACRIN trials.
29. Longitudinal changes in financial burden in patients with colorectal cancer treated with curative intent: Primary results of EAQ162CD.
30. The National Lung Screening Trial's Endpoint Verification Process: Determining the cause of death
31. Association Between Surgery Preference and Receipt in Ductal Carcinoma In Situ After Breast Magnetic Resonance Imaging
32. A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG‐ACRIN Cancer Research Group (EAQ152)
33. IDEAS and New IDEAS: Amyloid PET in diverse populations
34. Primary Care Provider-Delivered Smoking Cessation Interventions and Smoking Cessation Among Participants in the National Lung Screening Trial
35. Tolerability of bevacizumab and chemotherapy in a phase 3 clinical trial with human epidermal growth factor receptor 2–negative breast cancer: A trajectory analysis of adverse events
36. Patient-Reported Testing Burden of Breast Magnetic Resonance Imaging Among Women With Ductal Carcinoma In Situ
37. Fatigue and endocrine symptoms among women with early breast cancer randomized to endocrine versus chemoendocrine therapy: Results from the TAILORx patient‐reported outcomes substudy
38. Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial)
39. Impact of Dedicated Brain PET on Intended Patient Management in Participants of the National Oncologic PET Registry
40. Cost-Effectiveness of CT Screening in the National Lung Screening Trial
41. Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial
42. Risk Perceptions Among Participants Undergoing Lung Cancer Screening: Baseline Results from the National Lung Screening Trial
43. Association of Modifiable Risk Factors With Early Discontinuation of Adjuvant Endocrine Therapy
44. Engaging the radiology community in the National Clinical Trials Network: The ECOG-ACRIN TMIST experience.
45. Predictors of surgery preference and quality of life in DCIS after breast MRI: A trial of the ECOG-ACRIN Cancer Research Group (E4112).
46. Association between allostatic load, symptom burden and mortality in E1A11 trial for myeloma.
47. Baseline and short-term financial burden (FB) in colorectal cancer (CRC) treated with curative intent: Early results of ECOG-ACRIN EAQ162CD.
48. Results of the Two Incidence Screenings in the National Lung Screening Trial
49. Examining whether lung screening changes risk perceptions: National Lung Screening Trial participants at 1-year follow-up
50. Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae. (Major Article)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.